IDL Diagnostics (Q4 Review): Aims to broaden the sales model - Redeye
Bildkälla: Stockfoto

IDL Diagnostics (Q4 Review): Aims to broaden the sales model - Redeye

IDL saw a comeback in TUBEX in Q3, and total sales came in SEK1m above our forecast, with OPEX relatively in line. In 2026, we are encouraged by IDL's efforts to diversify its sales model, adding new geographies and product segments. The share trades at undemanding multiples but is constrained by low turnover.

IDL saw a comeback in TUBEX in Q3, and total sales came in SEK1m above our forecast, with OPEX relatively in line. In 2026, we are encouraged by IDL's efforts to diversify its sales model, adding new geographies and product segments. The share trades at undemanding multiples but is constrained by low turnover.
Börsvärldens nyhetsbrev